Weiwei Zhu
Hefei, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
An early integrated prognostic system for predicting relapse and guiding intervention post-CD19 CAR-T therapy in B-cell acute lymphoblastic leukaemia.
Journal: British journal of haematology
Published: January 18, 2026
Elevated circulating CD10-granulocytic myeloid-derived suppressor cells correlate with disease activity and poor prognosis in patients with diffuse large B-cell lymphoma.
Journal: Annals of hematology
Published: April 02, 2025
Lipid levels and multiple myeloma risk: insights from Meta-analysis and mendelian randomization.
Journal: Lipids in health and disease
Published: May 22, 2024
Prognostic value of 18F-fluorodeoxyglucose positron emission tomography/computed tomography at diagnosis in untreated multiple myeloma patients: a systematic review and meta-analysis.
Journal: Clinical and experimental medicine
Published: August 06, 2021
Integrative analysis of hub genes and key pathway in two subtypes of diffuse large B-cell lymphoma by bioinformatics and basic experiments.
Journal: Journal of clinical laboratory analysis
Published: June 24, 2021
Case Report: Combined Intravenous Infusion and Local Injection of CAR-T Cells Induced Remission in a Relapsed Diffuse Large B-Cell Lymphoma Patient.
Journal: Frontiers in immunology
Published: February 07, 2021
Anti-CD19 CAR-T cell therapy bridge to HSCT decreases the relapse rate and improves the long-term survival of R/R B-ALL patients: a systematic review and meta-analysis.
Journal: Annals of hematology
Published: August 09, 2020
Showing 1-8 of 8
Last Updated: 09/26/2026